Vaccines are very much necessary to getting children off to a healthy initiation of life. Because vaccination programs of the 20th and 21st century have been so successful, a number of parents today have never seen many vaccine-preventable diseases that were once common. Even they don’t realize that those infectious diseases could reemerge.
Infectious diseases that used to be common in children are polio, diphtheria, pertussis (whooping cough), rubella (German measles), and chickenpox – are can be prevent by vaccines which are approved by the U.S. Food and Drug Administration (FDA). Vaccines can prevent transmissible diseases that once killed or harmed many children, infants and adults. The FDA ensures that the vaccines children receive are safe and effective for their health.
Title : Vaccines and monoclonal antibodies in the prolonged treatment of non-small cell lung cancer: 20 years of follow-up
Mayra Ramos Suzarte, Center of Molecular Immunology, Cuba
Title : Observational study post emergency use authorization of itolizumab in the treatment of COVID-19
Mayra Ramos Suzarte, Center of Molecular Immunology, Cuba
Title : Vaccine for AML: 2023 and beyond
Stefan Gluck, Vice President, Global Medical Affairs at Celgene Corporation, United States
Title : Purification process development of COVID antigens to identify sera needed for plasma therapy
Sushmita Koley, Senior Scientist Bio-Rad Laboratories, United States
Title : Lessons that can be learned from the rollout of the COVID-19 vaccine and the acceptance of vaccination from healthcare professionals, frontline workers and patients that need to be considered in developing a vaccine
Regina Au, BioMarketing Insight, United States
Title : Lessons learned for the future of social listening to address vaccine misinformation
Joe Smyser, The Public Good Projects, United States
Title : Why Low-Energy-Electron Irradiation might be a potential game changer for vaccine development, manufacturing, and pandemics prevention
Daniel Becker, KyooBe Tech GmbH, Germany
Title : National immunization management system- NIMS
Kashif Zulfiqar, Project Manager - NADRA, Pakistan
Title : Medicinal synthetic aluminum-magnesium silicate {Al4 (SiO4)3 + 3Mg2SiO4?2Al2 Mg3 (SiO4)3} effective for: Viral diseases; Tumors; Antimicrobial resistant infections
Maduike Chiehiura Onwubiko Ezeibe, Michael Okpara University of Agriculture, Nigeria
Title : Moving the needle for covid-19 vaccinations in Nigeria through leadership, accountability, and transparency
Fejiro Chinye Nwoko, Nigeria Solidarity Support Fund, Nigeria